SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma

Overview of attention for article published in CTS: Clinical & Translational Science, May 2021

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 38 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,917 followers.

SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma https://t.co/Ob12mHFRAu

New article: SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma https://t.co/6b1SRnYc51 #pancreaticcancer #oncology https://t.co/8w3KKOcMpP

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.